Nintedanib as a novel treatment option in hereditary haemorrhagic telangiectasia

A 70-year-old patient with known hereditary haemorrhagictelangiectasia (HHT) was seen regularly in our outpatient clinic. He underwent multiple therapeutical interventions, including both surgical and medical, for the treatment of recurrent epistaxis without sustained success. Due to a concurrent di...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMJ Case Rep
Autori principali: Kovacs-Sipos, Evelin, Holzmann, David, Scherer, Thomas, Soyka, Michael B
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Publishing Group 2017
Soggetti:
Novel Treatment (New Drug/Intervention; Established Drug/Procedure in New Situation)
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5747615/
https://ncbi.nlm.nih.gov/pubmed/28652319
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2017-219393
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi